PRESS RELEASE published on 03/07/2025 at 16:30, 1 year 2 months ago Viromed Medical AG: Strategic healthcare investor acquires further shares in private placement Strategic healthcare investor acquires further shares in Viromed Medical AG through private placement. Majority shareholder Uwe Perbandt reallocates 900,000 shares. Investor now holds 10.62% shares Private Placement Shareholder Strategic Investor Viromed Medical AG Healthcare Investor
PRESS RELEASE published on 03/07/2025 at 16:30, 1 year 2 months ago Point d'étape de Versity Versity SA fait un point sur son activité avec acquisition d'INEUF.com, expansion, partenariat stratégique et procédure en cours. Prévision forte augmentation du chiffre d'affaires en 2025 Chiffre D'affaires Acquisition Partenariat Stratégique Versity SA INEUF.com
PRESS RELEASE published on 03/07/2025 at 16:27, 1 year 2 months ago CLINUVEL: Record Half-Year Confirms Growth Trajectory – PARMANTIER & CIE. Presents Latest Research Study on CLINUVEL Pharmaceuticals' Half-Year Results CLINUVEL Pharmaceuticals Ltd. reports record-breaking figures for H1 of fiscal year 2025, surpassing market expectations with strong revenue and EPS growth. Dr. Philippe Wolgen's leadership and strategic foresight driving sustainable success Revenue Increase CLINUVEL Pharmaceuticals Record-breaking Figures Dr. Philippe Wolgen Strategic Foresight
PRESS RELEASE published on 03/07/2025 at 16:23, 1 year 2 months ago EQS-Adhoc: NORMA Group SE: Management Board approves guidance for the 2025 financial year NORMA Group SE Management Board approves guidance for 2025 financial year amidst uncertainties, deviating from market expectations. Full outlook in Annual Report 2024 Management Board Guidance Market Expectations NORMA Group SE 2025 Financial Year
PRESS RELEASE published on 03/07/2025 at 16:21, 1 year 2 months ago Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH): BUY CLINUVEL Pharmaceuticals demonstrates impressive H1/FY25 results, increasing revenue and EPS. New strategy focuses on vitiligo treatment, leading in science-based cosmetic products Investment Recommendation CLINUVEL Pharmaceuticals H1/FY25 Results Vitiligo Treatment Cosmetic Products
PRESS RELEASE published on 03/07/2025 at 15:30, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 13.69% interest in American Axle & Manufacturing Holdings, Inc. through Form 8.3. Delivered on 06 March 2025 Securities Form 8.3 Disclosure Vanguard Group American Axle & Manufacturing
PRESS RELEASE published on 03/07/2025 at 15:29, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group discloses 3.63% ownership in Dalata Hotel Group plc as of 06 March 2025 Irish Takeover Panel The Vanguard Group Ownership Disclosure Financial Disclosure Dalata Hotel Group Plc
PRESS RELEASE published on 03/07/2025 at 15:28, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc The Vanguard Group, Inc. files Form 8.3 related to TI Fluid Systems plc disclosing a 3.89% interest in the company's 1p ordinary shares Securities Form 8.3 Disclosure Vanguard Group TI Fluid Systems Plc
PRESS RELEASE published on 03/07/2025 at 15:28, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.37% ownership in Direct Line Insurance Group plc as of 06 March 2025. Purchase of 30,376 securities at 2.76 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Direct Line Insurance Group
PRESS RELEASE published on 03/07/2025 at 15:27, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses a 5.56% stake in Assura plc through relevant securities. Purchase of 10p ordinary shares at 0.40 GBP per unit Securities The Vanguard Group Purchase Stake Assura Plc
Published on 05/08/2026 at 23:00, 15 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 45 minutes ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 45 minutes ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 21:00, 2 hours 15 minutes ago NOA Lithium Receives Biannual Renewal to Rio Grande's Exploration Permits and Provides Corporate Updates
Published on 05/08/2026 at 20:38, 2 hours 36 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 4 hours 2 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 4 hours 12 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 4 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 4 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 4 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 4 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 4 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL